Global Digital Neuro Biomarkers Market Size Study, by Type, by Clinical Practice, by End Use and Regional Forecasts 2022-2032

Description

The Global Digital Neuro Biomarkers Market was valued at approximately USD 593.1 million in 2023 and is expected to grow at a significant compound annual growth rate (CAGR) of 25.3% over the forecast period from 2024 to 2032. The increasing integration of technology in healthcare is a key driver of this growth, reflecting the market's rapid expansion. Digital neuro biomarkers are pivotal in transforming the landscape of neurological healthcare by providing real-time, continuous monitoring of patients' neurological health through digital platforms, including wearables, mobile applications, and sensors. These digital tools are instrumental in detecting and tracking the progression of neurodegenerative disorders such as Parkinson's, Alzheimer's, and multiple sclerosis, thereby facilitating more personalized and responsive treatment strategies.

The surge in the prevalence of chronic neurological diseases, coupled with the advancements in digital health technologies, is driving the demand for digital neuro biomarkers. The ability to capture a wide range of health metrics-such as movement patterns, speech analysis, and cognitive functions-through non-invasive digital platforms offers unprecedented insights into a patient's neurological status. This approach not only enhances the management of neurological conditions but also plays a critical role in clinical trials, where digital biomarkers are increasingly being used to evaluate the efficacy of new therapeutics.

Moreover, the collaboration between technology firms, healthcare providers, and research institutions is fostering innovation and expanding the applications of digital neuro biomarkers across different therapeutic areas. The rising adoption of remote patient monitoring and the growing emphasis on personalized medicine further underscore the importance of digital biomarkers in modern healthcare. The market is also witnessing substantial investments in research and development, aimed at enhancing the precision and utility of these digital tools, which is expected to propel the market's growth in the coming years.

The key regions considered in the study include Asia Pacific, North America, Europe, Latin America, and the Middle East and Africa. North America held the dominant market share in 2023, driven by a high prevalence of neurological disorders, advanced healthcare infrastructure, and robust R&D activities. The market in Europe is also experiencing significant growth, fueled by technological advancements and increasing focus on personalized medicine. Meanwhile, the Asia Pacific region is anticipated to witness the fastest growth over the forecast period, driven by rising investments in healthcare technology and the increasing burden of neurological disorders.

Major market players included in this report are:

Altoida Inc.
Koneksa
Biogen Inc.
Roche (Navify)
NeuraMetrix
Merck KGaA
Linus Health
Neurotrack Technologies, Inc.
Huma
NeuraLight
Cumulus Neuroscience
NeuroSense Therapeutics Ltd.
Verily Life Sciences LLC
Head Diagnostics
Revibe Technologies

The detailed segments and sub-segments of the market are explained below:

By Type

Wearable
Mobile-based Applications
Sensors
Others

By Clinical Practice

Diagnostic Digital Neuro Biomarkers
Monitoring Digital Neuro Biomarkers
Predictive and Prognostic Digital Neuro Biomarkers
Others

By End Use

Healthcare Companies
Healthcare Providers
Payers
Others

By Region:

North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
Rest of Europe
Asia Pacific
China
India
Japan
Australia
South Korea
Rest of Asia Pacific
Latin America
Brazil
Mexico
Rest of Latin America
Middle East & Africa
Saudi Arabia
South Africa
Rest of Middle East & Africa

Years considered for the study are as follows:

Historical year - 2022
Base year - 2023
Forecast period - 2024 to 2032

Key Takeaways:

Market Estimates & Forecast for 10 years from 2022 to 2032.
Annualized revenues and regional level analysis for each market segment.
Detailed analysis of geographical landscape with Country level analysis of major regions.
Competitive landscape with information on major players in the market.
Analysis of key business strategies and recommendations on future market approach.
Analysis of competitive structure of the market.
Demand side and supply side analysis of the market.

Chapter 1. Global Digital Neuro Biomarkers Market Executive Summary

1.1. Global Digital Neuro Biomarkers Market Size & Forecast (2022-2032)
1.2. Regional Summary
1.3. Segmental Summary
- 1.3.1. By Type
- 1.3.2. By Clinical Practice
- 1.3.3. By End Use
1.4. Key Trends
1.5. Recession Impact
1.6. Analyst Recommendation & Conclusion

Chapter 2. Global Digital Neuro Biomarkers Market Definition and Research Assumptions

2.1. Research Objective
2.2. Market Definition
2.3. Research Assumptions
- 2.3.1. Inclusion & Exclusion
- 2.3.2. Limitations
- 2.3.3. Supply Side Analysis
  - 2.3.3.1. Availability
  - 2.3.3.2. Infrastructure
  - 2.3.3.3. Regulatory Environment
  - 2.3.3.4. Market Competition
  - 2.3.3.5. Economic Viability (Consumer's Perspective)
- 2.3.4. Demand Side Analysis
  - 2.3.4.1. Regulatory frameworks
  - 2.3.4.2. Technological Advancements
  - 2.3.4.3. Environmental Considerations
  - 2.3.4.4. Consumer Awareness & Acceptance
2.4. Estimation Methodology
2.5. Years Considered for the Study
2.6. Currency Conversion Rates

Chapter 3. Global Digital Neuro Biomarkers Market Dynamics

3.1. Market Drivers
- 3.1.1. Rising Prevalence of Chronic Neurological Disorders
- 3.1.2. Technological Advancements in Digital Health Tools
3.2. Market Challenges
- 3.2.1. Data Privacy and Security Concerns
- 3.2.2. Regulatory Complexities
3.3. Market Opportunities
- 3.3.1. Growing Focus on Personalized Medicine
- 3.3.2. Increasing Adoption of Remote Patient Monitoring

Chapter 4. Global Digital Neuro Biomarkers Market Industry Analysis

4.1. Porter's 5 Force Model
- 4.1.1. Bargaining Power of Suppliers
- 4.1.2. Bargaining Power of Buyers
- 4.1.3. Threat of New Entrants
- 4.1.4. Threat of Substitutes
- 4.1.5. Competitive Rivalry
- 4.1.6. Futuristic Approach to Porter's 5 Force Model
- 4.1.7. Porter's 5 Force Impact Analysis
4.2. PESTEL Analysis
- 4.2.1. Political
- 4.2.2. Economical
- 4.2.3. Social
- 4.2.4. Technological
- 4.2.5. Environmental
- 4.2.6. Legal
4.3. Top investment opportunity
4.4. Top winning strategies
4.5. Disruptive Trends
4.6. Industry Expert Perspective
4.7. Analyst Recommendation & Conclusion

Chapter 5. Global Digital Neuro Biomarkers Market Size & Forecasts by Type 2022-2032

5.1. Segment Dashboard
5.2. Global Digital Neuro Biomarkers Market: Type Revenue Trend Analysis, 2022 & 2032 (USD Million)
- 5.2.1. Wearable
- 5.2.2. Mobile-based Applications
- 5.2.3. Sensors
- 5.2.4. Others

Chapter 6. Global Digital Neuro Biomarkers Market Size & Forecasts by Clinical Practice 2022-2032

6.1. Segment Dashboard
6.2. Global Digital Neuro Biomarkers Market: Clinical Practice Revenue Trend Analysis, 2022 & 2032 (USD Million)
- 6.2.1. Diagnostic Digital Neuro Biomarkers
- 6.2.2. Monitoring Digital Neuro Biomarkers
- 6.2.3. Predictive and Prognostic Digital Neuro Biomarkers
- 6.2.4. Others

Chapter 7. Global Digital Neuro Biomarkers Market Size & Forecasts by End Use 2022-2032

7.1. Segment Dashboard
7.2. Global Digital Neuro Biomarkers Market: End Use Revenue Trend Analysis, 2022 & 2032 (USD Million)
- 7.2.1. Healthcare Companies
- 7.2.2. Healthcare Providers
- 7.2.3. Payers
- 7.2.4. Others

Chapter 8. Global Digital Neuro Biomarkers Market Size & Forecasts by Region 2022-2032

8.1. North America Digital Neuro Biomarkers Market
- 8.1.1. U.S. Digital Neuro Biomarkers Market
  - 8.1.1.1. Type breakdown size & forecasts, 2022-2032
  - 8.1.1.2. Clinical Practice breakdown size & forecasts, 2022-2032
- 8.1.2. Canada Digital Neuro Biomarkers Market
8.2. Europe Digital Neuro Biomarkers Market
- 8.2.1. U.K. Digital Neuro Biomarkers Market
- 8.2.2. Germany Digital Neuro Biomarkers Market
- 8.2.3. France Digital Neuro Biomarkers Market
- 8.2.4. Spain Digital Neuro Biomarkers Market
- 8.2.5. Italy Digital Neuro Biomarkers Market
- 8.2.6. Rest of Europe Digital Neuro Biomarkers Market
8.3. Asia Pacific Digital Neuro Biomarkers Market
- 8.3.1. China Digital Neuro Biomarkers Market
- 8.3.2. India Digital Neuro Biomarkers Market
- 8.3.3. Japan Digital Neuro Biomarkers Market
- 8.3.4. Australia Digital Neuro Biomarkers Market
- 8.3.5. South Korea Digital Neuro Biomarkers Market
- 8.3.6. Rest of Asia Pacific Digital Neuro Biomarkers Market
8.4. Latin America Digital Neuro Biomarkers Market
- 8.4.1. Brazil Digital Neuro Biomarkers Market
- 8.4.2. Mexico Digital Neuro Biomarkers Market
- 8.4.3. Rest of Latin America Digital Neuro Biomarkers Market
8.5. Middle East & Africa Digital Neuro Biomarkers Market
- 8.5.1. Saudi Arabia Digital Neuro Biomarkers Market
- 8.5.2. South Africa Digital Neuro Biomarkers Market
- 8.5.3. Rest of Middle East & Africa Digital Neuro Biomarkers Market

Chapter 9. Competitive Intelligence

9.1. Key Company SWOT Analysis
9.2. Top Market Strategies
9.3. Company Profiles
- 9.3.1. Altoida Inc.
  - 9.3.1.1. Key Information
  - 9.3.1.2. Overview
  - 9.3.1.3. Financial (Subject to Data Availability)
  - 9.3.1.4. Product Summary
  - 9.3.1.5. Market Strategies
- 9.3.2. Koneksa
- 9.3.3. Biogen Inc.
- 9.3.4. Roche (Navify)
- 9.3.5. NeuraMetrix
- 9.3.6. Merck KGaA
- 9.3.7. Linus Health
- 9.3.8. Neurotrack Technologies, Inc.
- 9.3.9. Huma
- 9.3.10. NeuraLight
- 9.3.11. Cumulus Neuroscience
- 9.3.12. NeuroSense Therapeutics Ltd.
- 9.3.13. Verily Life Sciences LLC
- 9.3.14. Head Diagnostics
- 9.3.15. Revibe Technologies

Chapter 10. Research Process

10.1. Research Process
- 10.1.1. Data Mining
- 10.1.2. Analysis
- 10.1.3. Market Estimation
- 10.1.4. Validation
- 10.1.5. Publishing
10.2. Research Attributes